CRISPR
The "Lab-in-a-Tube" TB test is stable across a range of temperatures, accepts blood, saliva, or sputum samples, and costs just under $3 per test.
Published on Monday, the work describes a foundational technology being commercialized by startup VedaBio.
The five-year grant will support the development of a palm-sized instrument and test strips that could provide results within the first weeks following infections.
The assays can be used to detect influenza A and influenza B, distinguish between flu subtypes, and identify strains that are resistant to antiviral treatment.
Top Five Articles on 360Dx Last Week: Biocept Bankruptcy; 3EO Health NIH Grant; More
Last week, readers were most interested in a story about Biocept's Chapter 7 bankruptcy filing.
May 11, 2023
Sep 2, 2022
May 31, 2022